To determine the frequency of brain metastasis in lung cancer at the time of diagnosis.
lung cancer (27730 non-small cell carcinomas and 3720 small cell cacinomas) according to clinical tumor status (cT factor) and nodal status (cN factor) . Results. Brain metastasis was observed in 1104 (4.0%) patients with non-small cell carcinoma and in 279 (7.5%) patients with small cell carcinoma. In 653 patients with non-small cell carcinoma and 163 patients with small cell carcinoma, there was no other metastatic lesion except brain metastasis. Frequency of brain metastasis was 4.8% in adenocarcinoma, 2.5% in squamous cell carcinoma, 6.4% in large cell carcinoma and 1.7% in adenosquamous cell carcinoma. Frequency of brain metastasis was higher in advanced clinical tumor status and nodal status, especially in non-small cell carcinoma with advanced nodal status. Median survival time (MST) of patients with brain metastasis was 21.4 weeks in non-small cell carcinoma and 28.1 weeks in small cell carcinoma. MST Figure  1 . Survival curves of patients with brain metastasis of lung cancer. 
